Global Stem Cells Group Announces Agreement with Singapore Stem Cell Training Network
Global Stem Cells Group has announced a new agreement with Bangkok, Thailand-based Global Stem Cells Network and its affiliate Global Medical Training Network for qualified physician referrals from the Philippines, Thailand and Singapore to be trained in the latest stem cell therapies.
MIAMI, Fla., Feb. 10, 2016—Global Stem Cells Group, a world leader in regenerative medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical Training Network to train qualified physicians from the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies.
Through the new collaboration, Global Stem Cells Group and its Affiliate Stem Cell Training, Inc. have scheduled six, two-day intensive “Adipose and Bone Marrow Training Course” programs at its training facilities in several cities around the world for GSCN-referred physicians between March and October, 2016.
In addition, Global Stem Cells Group will host training for its graduate course, “Diplomat in Cell Therapy and Tissue Engineering” in June and December, 2016.
Global Stem Cells Group CEO Benito Novas says the agreement with GSCN and Global Medical Training Network is the latest in the international biotech company’s ongoing expansion efforts to bring stem cell treatments to communities worldwide.
“We are very pleased to be working with GSCN, and see this as a great opportunity to prove how valuable a collaboration between two international stem cell providers with the same goals can be,” Novas says.
GSCN’s Global Medical Training Network is made up of industry leaders, specialist physicians and researchers who have joined together to offer breakthrough information and training on the latest medical innovations, products and consumer trends in regenerative and anti-aging medicine.
“Though our collaboration with Global Stem Cells Group, we are confident that our goal to make stem cell medicine a cornerstone of best medical practices worldwide is at hand, and we’re excited to be in the forefront of the future of regenerative medicine,” says GSCN Finance Manager Zunaid Ibne Raihan.
For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.
About Global Stem Cell Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Stem Cells Training:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.
About Global Stem Cells Network (GSCN):
Bangkok, Thailand-based Global Stem Cells Network is made up of internationally-trained physicians and health care professionals dedicated to providing the safest, most effective stem cell treatments available today. GSCN is a recognized and trusted leader in providing stem cell specialist treatment programs since 2010, and related medical care since 2003.
About Global Medical Training Network (GMTN):
Global Medical Training Network offers a platform for like-minded physicians and other healthcare professionals to further their own education, enhance their medical practice and incorporate cutting edge procedures and products that work.
Uniquely positioned at the center of an ambitious healthcare group, GMTN specializes in integrative medicine, owns and operates several clinics and two medical tourism companies, supports research projects and maintains close ties with advanced regional product distributors. GMTN provides access to the latest stem cell and regenerative medicine information through trainings, lectures, webinars, EDMs and social networks.
- Published in Press Releases
Global Stem Cells Group Announces Members of Advisory Board to Speak at the Latin American A4M Anti-Aging Medicine Conference in Mexico City
Global Stem Cells Group, has announced that two GSCG Advisory Board members, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the Latin American Chapter of the American Academy of Anti-Aging Medicine (A4M) VII World Congress in Mexico City, Feb. 12, 13 and 14 2016.
MIAMI, Jan. 21, 2016—Global Stem Cells Group, a world leader in regenerative medicine, has announced that two members of its Advisory Board, Joseph Purita, M.D. and Gilberto Hernandez Falcon, M.D., will be keynote speakers at the American Academy of Anti-Aging Medicine (A4M) Latin American Chapter of the VII World Congress Feb. 12, 13 and 14 2016.
The conference will focus on recent technological and scientific advances in anti-aging medicine that are becoming indispensible in the prevention, prediction, detection, treatment and rehabilitation of diseases that occur with advancing age. This conference will focus on new treatments and protocols to extend years and improve patient quality of life.
Conference topics include recent protocols in weight control and obesity, platelet rich plasma therapies, menopause, sexual health and hormonal balance, alternative medicine for stress and sleep disorders, LED laser and thermal heat treatments, biodentical hormone replacement therapy and its clinical applications, oxygen and ozone therapies, recent advances in cellular therapies for cosmetic applications and much more.
Purita, who heads the Global Stem Cells Group Advisory Board, is a pioneer in the use of stem cell therapies in orthopedics. He will speak on the latest advances in evidence-based, best-practice protocols for the early detection, prevention and treatment of medical problems associated with aging.
The conference will be held at the Hotel Fiesta Americana Reforma in Mexico City.
For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.
About Global Stem Cell Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
###
To view this press release live online, please click here
- Published in Press Releases
Global Stem Cells Announces the 2016 International Academic Year Inaugural Convention in Santiago, Chile
Global Stem Cells Group will present the largest global network of medical leaders and physicians from an array of disciplines and practices worldwide, as well as their representatives, franchises and partners at the 2016 International Academic Year Inaugural Convention March 25, 25 and 27 in Santiago, Chile.
MIAMI, Jan. 19, 2016—Global Stem Cells Group, a world leader in regenerative medicine, will host the 2016 International Academic Year Inaugural Convention March. 25-27, 2016 in Santiago, Chile. The convention will kick off the New Year by gathering the largest global network of medical leaders and physicians from around the world to formally sign a joint venture between GSCG and Santiago-based Cellus Regenerative Medicine, SA.
Global Stem Cells Group COO Kipp Van Camp will be in Santiago to execute the agreement between GSCG and Cellus, and to supervise GSCG’s new facilities and protocols to be used in its medical tourism initiative.
David Audley, Chair and General Secretary of the Regentech Alliance (RTA), will be on hand to conduct the GSCG Chile facility’s RTA certification process. The RTA certification signifies that GSCG Chile meets the highest standards of excellence in current medical and laboratory practices as measured by established standards.
The mission of the conference s to educate the medical community on the latest advances in regenerative medicine, and will feature experts in regenerative medicine, including:
Spain
• Augusti Molins, M.D. of the Medical Center in Barcelona. Molins specializes in nutrition and dietetics, the protein diet Sulço® method, obesity and overweight children, ozone therapy, carboxitherapy, aesthetic medicine cosmetic surgery. Spain.
U.S.
• Kipp Van Kamp, D.O., interventional radiologist, Global Stem Cells Group COO, regenerative medicine expert. A graduate of Kansas City University of Physicians and Surgeons, affiliated with The Clara Barton Hospital Association Inc. in Hoisington, Kansas and Critical Imaging Associates in Topeka, Kansas.
. Chile
• Enrique Testart, M.D., trauma surgeon, pediatric microsurgeon, regenerative medicine specialist, surgeon/manager Innovassalud, S.A. German clinic in Santiago, founder, ConsortiaInnovas S.A., Global Stem Cells Group Chile CEODavid Audley, (U.S.) international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
. U.S.
• David Audley, international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
. Following the conference, Global Stem Cells Group will conduct a special training course to include regenerative medicine body preparations using vitamin combinations and other nutritional supplements to enhance stem cell function.
The conference will take place at the Marriott Hotel in Santiago, AV. Pdte. Kennedy 5741 –Vitacura.
For more information on the 2016 International Academic Year Inaugural Convention in Santiago, Chile visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-224-1858.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Cellus Regenerative Medicine, SA.:
Cellus is dedicated to research, development and commercialization of therapeutic services and custom biotech products in the field of regenerative medicine. Their multidisciplinary team of stem cell experts focuses on the prevention and reversal of impairment in the skin of patients with traumatic injuries, skin diseases or symptoms of aging.
Their state-of-the-art facility in Santiago features a full laboratory and showcases the company’s extensive clinical expertise and biopharmaceutical production capabilities.
To view this press release live online, click here.
###
- Published in Press Releases
- 1
- 2